Acclinate connects you to the communities, data, and intelligence you need to understand patient needs, uncover barriers, and take action that drives measurable impact. Powered by our 315K+ member NOWINCLUDED community and AVA intelligence platform, we help life sciences organizations make decisions that lead to meaningful results.
Community intelligence, in one place: who is ready, what stands in the way and what to do next.
Ask in plain language. AVA answers from community data and suggests a next step.




Start with a community that's already engaged. AVA runs on NOWINCLUDED, where people from underrepresented communities come to be heard and take action for better health.
Meet the community ↓of sponsors say they are not meeting their representation goals.
Source: Flanagan, J. & Evers, J. (2023). How Customer-First Clinical Trials Cut Complexity and Delays. Bain & Company.
See representation gaps before the protocol is final, so there are fewer questions about who your results apply to and fewer post-marketing surprises.
Trial design, eligibility and site selection can unintentionally limit representative enrollment. AVA shows how communities see your sites, what blocks access and what moves people to join.
Carry the same community insight into launch planning, so payers, providers and patients see evidence that reflects them.
Planning your next program? Integrate community intelligence from day one.
Why Acclinate →Request a demoSupporting R&D, clinical, commercial and health equity teams, from first protocol draft to launch.
Not sure where to start? Tell us about your next program →
Health system, payer or provider? See how we work with you →
Life sciences companies, CROs, health systems and community organizations work with Acclinate. Backed by strategic investment from Labcorp and Cencora.





.png)





.png)


Every signal in AVA starts with a person: at a health walk, a church hall, a salon or a kitchen table.
Learn about NOWINCLUDED →COPD study with a leading biotechnology research company. 36 community events across five metros over 15 months.
1.5M+ people reached with gut health and IBD education, and 11K+ NOWINCLUDED members offered the opportunity to take part.
With the Multiple Myeloma Research Foundation. 79% to 86% of attendees felt inspired to prioritize their health or promote awareness in their communities.
“Pharmacies are uniquely positioned at the intersection of trust and access in healthcare.”
“I had never known anyone healthy with this condition before today… now I know I'm not alone fighting this…”
Bring a therapeutic area. We'll show you where people are and what it takes to reach them.